Propofol infusion syndrome

American Journal of Therapeutics

Volumn 17, Issue 5, 2010, Pages 487-491

  Wong, Jeremy M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

lactic acidosis; metabolic acidosis; propofol; propofol infusion syndrome

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALCOHOL; CARNITINE; CATECHOLAMINE; CREATINE KINASE; EDETIC ACID; FATTY ACID; LACTIC ACID; METFORMIN; NITROPRUSSIDE SODIUM; PROPOFOL; PROPYLENE GLYCOL; REMIFENTANIL; RNA DIRECTED DNA POLYMERASE INHIBITOR; SALICYLIC ACID; ZINC;

ANESTHESIA COMPLICATION; ANION GAP; ARTIFICIAL VENTILATION; ASYSTOLE; AUTOPSY; BRADYCARDIA; CARBON MONOXIDE INTOXICATION; CARDIOGENIC SHOCK; CARNITINE DEFICIENCY; CLINICAL STUDY; CREATINE KINASE BLOOD LEVEL; CRITICALLY ILL PATIENT; CROUP; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; ECHOCARDIOGRAPHY; EPIGLOTTIS; EXTRACORPOREAL OXYGENATION; FATTY ACID OXIDATION; FATTY LIVER; HEART FAILURE; HEART OUTPUT; HEMODIALYSIS; HEPATOMEGALY; HUMAN; HYPERLIPIDEMIA; HYPOTENSION; HYPOVOLEMIA; HYPOXEMIA; HYPOXIA; INCIDENCE; INFUSION RATE; INTENSIVE CARE UNIT; ISCHEMIA; LACTIC ACIDOSIS; METABOLIC ACIDOSIS; MORTALITY; MUSCLE BIOPSY; MYOGLOBINURIA; OXYGEN CONSUMPTION; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; REVIEW; RHABDOMYOLYSIS; RISK FACTOR; SAFETY; SEDATION; SEPSIS; SEPTIC SHOCK; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYCARDIA; TACHYPNEA; TREATMENT CONTRAINDICATION;

ACIDOSIS; ACUTE KIDNEY INJURY; ANESTHETICS, INTRAVENOUS; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE; HUMANS; HYPERKALEMIA; HYPERTRIGLYCERIDEMIA; MALE; PROPOFOL; RHABDOMYOLYSIS;

EID: 77957790013     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181ed837a     Document Type: Review

References (22)

1. Bray RJ. Propofol infusion syndrome in children. Paed Anaesth. 1998;8:491-499.
2. Kam PCA, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007;62:690-701.
3. Parke TJ, Stevens JE, Rice ASC, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. Br Med J. 1992;305:613-616.
4. Ahlen K, Buckley CJ, Goodale DB, et al. The 'propofol infusion syndrome': the facts, their interpretation and implications for patient care. Eur J Anaesth 2006;23: 990-998.
5. Marinella MA. Lactic acidosis associated with propofol. Chest. 1996;109:292.
6. Perrier ND, Baerga-Varela Y, Murray J. Death related to propofol use in an adult patient. Crit Care Med. 2000;28: 3071-3074.
7. Cremer OL, Moons KGM, Bouman EAC, et al. Long term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357:117-118.
8. Mehta N, De Munter C, Habibi, et al. Short-term propofol infusions in children. Lancet. 1999;354:866-867.
9. Burow BK, Johnson ME, Packer DL. Metabolic acidosis associated with propofol in the absence of other causative factors. Anesthesiology. 2004;101:239-241.
10. Salengros JC, Velghe-Lenelle CE, Bollens R, et al. Lactic acidosis during propofol-remifentanil anesthesia in an adult. Anesthesiology. 2004;101:241-243.
11. Cravens GT, Packer DL, Johnson ME. Incidence of propofol infusion syndrome during noninvasive radio-frequency ablation for atrial flutter or fibrillation. Anesthesiology. 2007;106:1134-1138.
12. Rozet I, Tontisirin N, Vavilala MS, et al. Prolonged propofol anesthesia is not associated with an increase in blood lactate. Anesth Analg. 2009;109:1105-1110.
13. Gottschling S, Meyer S, Krenn T, et al. Effects of short-term propofol administration on pancreatic enzymes and triglyceride levels in children. Anaesthesia. 2005;60: 660-663.
14. Vernooy K, Delhaas T, Cremer OL, et al. Electrocardio-graphic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm. 2006;3:131-137.
15. Fong JJ, Sylvia L, Ruthazer R, et al. Predictors of mortality in patients with suspected propofol infusion syndrome. Crit Care Med. 2008;36:2281-2287.
16. Wysowski D, Pollock M. Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) seda-tion and literature review. Anesthesiology. 2006;105: 1047-1051.
17. Roberts R, Barletta J, Fong J, et al. Incidence of propofol-related infusion syndrome in critically ill adults: a pro-spective, multicenter study. Crit Care. 2009;13:R169.
18. Vasile B, Rasulo F, Candiani A, et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intens Care Med. 2003;29:1417-1425.
19. Wolf A, Weir P Segar P, et al. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet. 2001;357:606-607.
20. Uezono S, Hotta Y, Takakuwa Y, et al. Acquired carnitine deficiency: a clinical model for propofol infusion syn-drome? Anesthesiology 2005;103:909.
21. Ypsilantis P, Politou M, Mikroulis D, et al. Organ toxicity and mortality in propofol-sedated rabbits under prolonged mechanical ventilation. Anesth Analg. 2007;105:155-166.
22. Enting D, Ligtenberg JJ, Aarts LP, et al. Total suppression of cerebral activity by thiopental mimicking propofol infusion syndrome: a fatal common pathway? Anesth Analg. 2005;100:1864-1865; author reply 1865.